REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 70 filers reported holding REGULUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 3.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,723,000 | -53.4% | 1,210,121 | -31.6% | 0.00% | 0.0% |
Q3 2016 | $5,838,000 | +20.3% | 1,769,086 | +5.4% | 0.00% | 0.0% |
Q2 2016 | $4,853,000 | -50.8% | 1,679,088 | +18.0% | 0.00% | -50.0% |
Q1 2016 | $9,863,000 | -17.6% | 1,423,233 | +3.7% | 0.00% | -33.3% |
Q4 2015 | $11,970,000 | +23.6% | 1,372,711 | -7.3% | 0.00% | 0.0% |
Q3 2015 | $9,687,000 | -37.2% | 1,481,195 | +5.2% | 0.00% | -25.0% |
Q2 2015 | $15,435,000 | -14.0% | 1,408,287 | +32.9% | 0.00% | 0.0% |
Q1 2015 | $17,951,000 | +12.1% | 1,059,704 | +6.2% | 0.00% | 0.0% |
Q4 2014 | $16,013,000 | +174.9% | 998,306 | +17.0% | 0.00% | +100.0% |
Q3 2014 | $5,826,000 | -14.7% | 852,959 | +0.4% | 0.00% | 0.0% |
Q2 2014 | $6,828,000 | -7.3% | 849,286 | +4.1% | 0.00% | 0.0% |
Q1 2014 | $7,362,000 | +31.5% | 816,211 | +7.7% | 0.00% | 0.0% |
Q4 2013 | $5,598,000 | +104.7% | 757,577 | +161.2% | 0.00% | +100.0% |
Q3 2013 | $2,735,000 | +24.3% | 290,067 | +29.3% | 0.00% | 0.0% |
Q2 2013 | $2,201,000 | – | 224,316 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 3,790,476 | $41,544,000 | 4.18% |
Foresite Capital Management II, LLC | 893,781 | $9,796,000 | 3.44% |
Abingworth LLP | 327,350 | $3,588,000 | 1.63% |
Cormorant Asset Management, LP | 896,522 | $9,826,000 | 1.31% |
Trellus Management Company, LLC | 80,000 | $877,000 | 0.99% |
ORACLE INVESTMENT MANAGEMENT INC | 741,804 | $8,130,000 | 0.99% |
WEDBUSH SECURITIES INC | 93,165 | $1,021,000 | 0.19% |
SABBY MANAGEMENT, LLC | 344,667 | $3,778,000 | 0.14% |
BOURGEON CAPITAL MANAGEMENT LLC | 20,260 | $222,000 | 0.13% |
Perceptive Advisors | 200,000 | $2,196,000 | 0.13% |